EANO Welcomes New President: Roberta Rudà
The EANO Meeting 2026 in Rome has come to a close, and what a congress it was! Over several days, Neuro-Oncology colleagues from across Europe and beyond gathered for inspiring sessions, lively discussions, and valuable new connections. Thank you to everyone who joined us, and to the speakers, chairs, and organizers whose contributions made the program so rewarding.
The meeting also marked an important moment for our association. Following a soccesful Rome Meeting 2026, we are delighted to welcome Roberta Rudà as EANO's new President.At the same time, we want to express our heartfelt thanks to Michael Platten, who now steps down as President and becomes Past President. Under his leadership, EANO has continued to grow as a community for everyone working in Neuro-Oncology. We are truly grateful for his dedication, commitment, and the energy he invested in our association. Thank you, Michael, for everything you have done for EANO!
About Roberta Rudà
Dr. Roberta Rudà is Professor of Neurology at the University of Turin, where she has been active in Neuro-Oncology for 25 years. Since 2022, she has chaired the Division of Neuro-Oncology in the University's Department of Neuroscience and coordinates the Multidisciplinary Brain Tumor Board at the City of Health and Science Hospital/University of Turin.
She served on the EANO Executive Board from 2016 to 2024 and has led two major European guidelines, published in Neuro-Oncology: the EANO Guideline on Ependymal Tumors, and the EANO-EURACAN-SNO Guideline on Rare Glial, Glioneuronal and Neuronal Tumors.
From 2017 to 2022, she was President of the Italian Association of Neuro-Oncology (AINO), and since 2022 she has co-chaired the Neuro-Oncology Panel of the European Academy of Neurology (EAN). She is also active in several international RANO groups (Seizures, Liquid Biopsy, Leptomeningeal Diseases, RANO Resect and PET-RANO) and leads the Ependymoma subgroup within the EORTC Brain Tumor Group's Glio-Rare study.
Her research centers on IDH mutant gliomas, rare brain tumors (especially ependymomas), and brain tumor-related epilepsy, with additional interests in translational research, functional neuroimaging, and neurological complications of cancer. She has authored more than 250 papers in high-impact journals and has served as Principal Investigator on numerous national and international clinical trials.
We look forward to the next chapter of EANO under Roberta's leadership, and to seeing you all again at next year's meeting.
Call for applications to host EANO Seminars 2028
The EANO Educational Committee invites you to submit a bid to host the EANO Seminars 2028 in locations that usually do not host EANO Meetings or EANO Seminars.
EANO Seminars is an educational event that aims to provide an update on the recent advances in the pathogenesis and management of CNS tumors with particular attention devoted to the application in the clinical practice. It is aimed to attract scientists, physicians and healthcare professionals involved in diagnosis and treatment of brain tumors, and is aimed mainly at junior staff from all over Europe.
Please find the bid requirements, expectations for the local host and further information here.
Submit your application to EANO Office at office@eano.eu by the deadline October 15, 2026, 23:59 CEST.
The EANO Educational Committee will review all applications and submit its recommendation to the Executive Board for final approval. All applicants will be notified of their application status by the end of December 2026.
If you have any questions or concerns, please do not hesitate to reach out to us.
We are looking forward to hearing from you!
On behalf of the
EANO Educational Committee
Why Become an EANO Member?
EANO is Europe’s multidisciplinary Neuro-Oncology organisation representing all medical and scientific disciplines involved in the prevention, diagnosis and treatment of tumours of the central nervous system (CNS). EANO is dedicated to promote advances in Neuro-Oncology through innovative research and concerted education and training. It enhances collaboration between all relevant disciplines - Neuro-Oncology, Neurosurgery, Neuropathology, Neuroradiology, and Radiation Oncology as well as Nursing - and aims at bridging science, knowledge and practice gaps in the management of CNS malignancies.
Today, EANO has over 1400 members from more than 60 countries. EANO stimulates (inter)national cooperation together with our major partner societies, the Society of Neuro-Oncology in the US (SNO) and the Asian Society of Neuro-Oncology (ASNO); together, EANO, SNO and ASNO are charter societies of the World Federation of Neuro-Oncology Societies (WFNOS).
The EANO Youngster Initiative provides a platform for exchange, networking and career support for young clinicians and scientists.
EANO provides multiple services to its members. We organise scientific and educational webinars and meetings with 'state of the art' lectures covering the broad spectrum of all disciplines in Neuro-Oncology, including our flagship annual EANO Meeting and the quadrennial WFNOS Meeting.
Further, EANO offers exclusively to its members free access to Neuro Oncology, Neuo Oncology Pediatrics, Neuro Oncology Practice and the Neuro Oncology Advances Journals.
EANO considers the preparation of multidisciplinary guidelines as a prime task to support the development of high quality care for brain tumour patients across Europe. The EANO Youngster Initiative is a highly active platform for exchange, networking and career support for young clinicians and scientists. We also offer high level post-graduate education through the EANO School of Neuro-Oncology launched in 2022 and strongly support increasing diversity in the Neuro-Oncology community.
Kind Regards
Roberta Rudà
EANO President (2026-2028)
